Human mesenchymal stem cell differentiation on bioactive glass-coated implants.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Osseointegration of titanium implants is crucial for clinical success but challenging.
• The role of surface coatings in promoting stem cell osteogenic differentiation is not fully understood.

Purpose of the Study:

• To evaluate the effect of bioactive glass (BG) coatings on human bone marrow mesenchymal stem cells (hBMSCs) osteogenic differentiation.
• To compare the efficacy of different BG compositions (45S5, Sr-BG, Zn-BG) on titanium implant surfaces.

Main Methods:

• Titanium discs were coated with 45S5 BG, Sr-BG, or Zn-BG.
• hBMSCs were cultured on coated and uncoated discs.
• Assessed cell viability, alkaline phosphatase activity, osteocalcin expression, and mineralized nodule formation at 7, 14, and 21 days.

Main Results:

• All BG-coated groups showed significantly higher cell viability, ALP activity, and calcium deposition than controls.
• Strontium-substituted BG (Sr-BG) exhibited the highest gene expression for RUNX2 and osteocalcin at day 21.
• Zinc-substituted BG (Zn-BG) also demonstrated enhanced osteogenic marker expression compared to controls.

Conclusions:

• Bioactive glass coatings, especially Sr-BG, significantly enhance hBMSC osteogenic differentiation on titanium.
• These findings suggest that Sr-BG coatings could improve the clinical success of titanium implants through better osseointegration.